Middle East Healthcare Company (TADAWUL:4009)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
22.95
-0.19 (-0.82%)
Nov 5, 2026, 3:16 PM AST

TADAWUL:4009 Financials Overview

Millions SAR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-3,1032,8832,6532,1521,873
Revenue Growth
-7.63%8.66%23.30%14.90%6.97%
Gross Profit
-1,1461,1021,004671.99595.14
Operating Income
-387.3440.93323.97140.3454.24
Net Income
-301.8828217.0475.1817.2
Earnings Per Share
-3.283.060.190.820.19
EPS Growth
-7.05%1555.10%-77.34%337.08%-79.02%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
In Patient Services
1,7851,7231,6281,5451,2391,098
Outpatient Services
987.48968.93852.68740.19587.88491.24
Others
12.133.288.776.5911.3417.66
Pharmacy Sales
404.21407.75393.25361.06313.54265.42
Total
3,1893,1032,8832,6532,1521,873

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
82.5426.352.2844.4215.628.13
Total Debt
2,4822,5442,4662,4852,2401,967
Net Cash (Debt)
-2,399-2,517-2,414-2,441-2,225-1,939
Net Cash Growth
------
Net Cash Per Share
--27.35-26.22-26.52-24.17-21.06

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-544.6766191.0876.0276.62
Capital Expenditures
--455.16-470.82-229.61-249.52-416.56
Free Cash Flow
-89.44295.18-38.53-173.5-339.94
Free Cash Flow Growth
--69.70%----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-36.94%38.23%37.83%31.23%31.78%
Operating Margin
-12.48%15.29%12.21%6.52%2.90%
Pretax Margin
-10.49%10.76%7.20%3.77%1.03%
Profit Margin
-9.73%9.78%0.64%3.49%0.92%
FCF Margin
-2.88%10.24%-1.45%-8.06%-18.15%

Dividends

Fiscal Year
CurrentFY 2025FY 2024
Period EndingNov '26 Dec '25 Dec '24
Dividend Per Share
0.5000.5000.500
Dividend Per Share Growth
0%0%-
Dividend Yield
2.18%1.54%0.73%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-9.9322.42476.9931.16169.35
Forward PE
11.3710.5222.9632.6224.5127.34
P/FCF Ratio
-33.5121.42---
PS Ratio
-0.972.193.061.091.56